[
  {
    "ts": "2026-02-19T14:55:58+00:00",
    "headline": "Where is Incyte Corporation (INCY) Headed According to Analysts?",
    "summary": "Incyte Corporation (NASDAQ:INCY) is one of the best immunotherapy stocks to buy according to hedge funds. Jefferies reiterated a Buy rating on Incyte Corporation (NASDAQ:INCY) on February 11, setting a price target of $120. The same day, Morgan Stanley also lifted the price target on the stock to $102 from $94 while maintaining an Equal […]",
    "url": "https://finance.yahoo.com/news/where-incyte-corporation-incy-headed-145558067.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "591ccdb8-9c31-392a-b095-9d9f878ddd30",
      "content": {
        "id": "591ccdb8-9c31-392a-b095-9d9f878ddd30",
        "contentType": "STORY",
        "title": "Where is Incyte Corporation (INCY) Headed According to Analysts?",
        "description": "",
        "summary": "Incyte Corporation (NASDAQ:INCY) is one of the best immunotherapy stocks to buy according to hedge funds. Jefferies reiterated a Buy rating on Incyte Corporation (NASDAQ:INCY) on February 11, setting a price target of $120. The same day, Morgan Stanley also lifted the price target on the stock to $102 from $94 while maintaining an Equal […]",
        "pubDate": "2026-02-19T14:55:58Z",
        "displayTime": "2026-02-19T14:55:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/1cc545eb3596ed209c0c0486654a1d8d",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Incyte Corporation (INCY): Among Small-Cap Healthcare Stocks Hedge Funds is Buying",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/F08AN_WgfDoxxGlrVQfGRQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/1cc545eb3596ed209c0c0486654a1d8d.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ux9OKsmqTigW_m7aYltcpQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/1cc545eb3596ed209c0c0486654a1d8d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/where-incyte-corporation-incy-headed-145558067.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/where-incyte-corporation-incy-headed-145558067.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INCY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]